Literature DB >> 24516034

Prognostic and predictive factors in patients with chronic lymphocytic leukemia: relevant in the era of novel treatment approaches?

Daniel Mertens1, Stephan Stilgenbauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24516034     DOI： 10.1200/JCO.2013.53.8421

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

Review 1.  The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia.

Authors:  Kruti Sheth Nair; Bruce Cheson
Journal:  Ther Adv Hematol       Date:  2016-02-03

Review 2.  Molecular pathogenesis of CLL and its evolution.

Authors:  David Rodríguez; Gabriel Bretones; Javier R Arango; Víctor Valdespino; Elías Campo; Víctor Quesada; Carlos López-Otín
Journal:  Int J Hematol       Date:  2015-01-29       Impact factor: 2.490

Review 3.  Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis.

Authors:  Mohammad Shahjahani; Javad Mohammadiasl; Fatemeh Noroozi; Mohammad Seghatoleslami; Saeid Shahrabi; Fakhredin Saba; Najmaldin Saki
Journal:  Cell Oncol (Dordr)       Date:  2015-01-07       Impact factor: 6.730

Review 4.  Antigen receptor stereotypy in chronic lymphocytic leukemia.

Authors:  K Stamatopoulos; A Agathangelidis; R Rosenquist; P Ghia
Journal:  Leukemia       Date:  2016-11-04       Impact factor: 11.528

5.  High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells.

Authors:  Sina Oppermann; Jarkko Ylanko; Yonghong Shi; Santosh Hariharan; Christopher C Oakes; Patrick M Brauer; Juan C Zúñiga-Pflücker; Brian Leber; David E Spaner; David W Andrews
Journal:  Blood       Date:  2016-06-13       Impact factor: 22.113

6.  Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model.

Authors:  Tycho Baumann; Julio Delgado; Rodrigo Santacruz; Alejandra Martínez-Trillos; Cristina Royo; Alba Navarro; Magda Pinyol; María Rozman; Arturo Pereira; Neus Villamor; Marta Aymerich; Cristina López; Anna Carrió; Emili Montserrat
Journal:  Haematologica       Date:  2014-06-27       Impact factor: 9.941

7.  Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients.

Authors:  C da Cunha-Bang; J Simonsen; K Rostgaard; C Geisler; H Hjalgrim; C U Niemann
Journal:  Blood Cancer J       Date:  2016-11-11       Impact factor: 11.037

8.  Real-world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres.

Authors:  Anthony Mato; Chadi Nabhan; Neil E Kay; Mark A Weiss; Nicole Lamanna; Thomas J Kipps; David L Grinblatt; Ian W Flinn; Mark F Kozloff; Christopher R Flowers; Charles M Farber; Pavel Kiselev; Arlene S Swern; Kristen Sullivan; E Dawn Flick; Jeff P Sharman
Journal:  Br J Haematol       Date:  2016-11-08       Impact factor: 6.998

Review 9.  Chronic lymphocytic leukemia: a clinical review including Korean cohorts.

Authors:  Young-Woo Jeon; Seok-Goo Cho
Journal:  Korean J Intern Med       Date:  2016-04-05       Impact factor: 2.884

10.  Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.

Authors:  Simar Pal Singh; Marjolein J W de Bruijn; Mariana P de Almeida; Ruud W J Meijers; Lars Nitschke; Anton W Langerak; Saravanan Y Pillai; Ralph Stadhouders; Rudi W Hendriks
Journal:  Front Immunol       Date:  2018-09-13       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.